Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression
Clinical trial NCT00322764 · COMPLETED
Trial details
- NCT number
- NCT00322764
- Sponsor
- Repligen Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.